Skip to main content
. 2016 May 11;8:53. doi: 10.1186/s13148-016-0220-7

Fig. 3.

Fig. 3

a Effect of RRx-001 (ABDNAZ) treatment on blood flow and tissue hypoxia in SCCVII tumors. b Comparison of RRx-001 (ABDNAZ) effect on tumor architecture, blood flow, hypoxia, and HIF1-α status in SCCVII tumors